Janux Therapeutics, Inc. (JANX)
Nasdaq: JANX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Who runs Janux Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Campbell David Alan
President and CEO. First filing Jun 2021, latest Jul 31, 2026, 7 filings in all.
Officers reporting now
8
of 19 people with a filing in the last fifteen months
Directors reporting now
11
32 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Campbell David Alan | President and CEO | Jun 2021 | Jul 31, 2026 | 1 · $100,000 |
| Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | May 2025 | Jun 4, 2026 | 1 · $100,000 |
| Dobek Maria | Vice President, Accounting | Aug 2024 | May 13, 2026 | 2 · $0.00 |
| Go William | Chief Medical Officer | Feb 2026 | Feb 4, 2026 | none |
| Diraimondo Thomas | Chief Scientific Officer | Jan 2024 | Jan 2, 2026 | 1 · $0.00 |
| Mciver Zachariah | Chief Medical Officer | Jan 2025 | Jan 2, 2026 | 1 · $0.00 |
| Meyer Andrew Hollman | Chief Business Officer | Jun 2021 | Jan 2, 2026 | 5 · $700,000 |
| Winter Charles M. | Chief Technical Officer | Jan 2023 | Jan 2, 2026 | 1 · $0.00 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Barrett Ronald W | director | Sep 2021 | Jun 12, 2026 | none |
| Capps Vickie L | director | Jun 2021 | Jun 12, 2026 | none |
| Dobmeier Eric | director | Jul 2024 | Jun 12, 2026 | none |
| Hernday Natasha | director | Jul 2024 | Jun 12, 2026 | none |
| Kolchinsky Peter | director | Jun 2021 | Jun 12, 2026 | none |
| Kung Winston | director | Sep 2022 | Jun 12, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Jun 2021 | Jun 12, 2026 | none |
| Ra Capital Management, L.P. | director | Jun 2021 | Jun 12, 2026 | none |
| Ra Capital Nexus Fund II, L.P. | director | Jun 2023 | Jun 12, 2026 | none |
| Shah Rajeev M. | director | Jun 2021 | Jun 12, 2026 | none |
| Simson Jake | director | Jun 2021 | Jun 12, 2026 | none |
Earlier names on the record17, newest filing first
Gujrathi Sheila · director · last filing Jun 2025Mcnulty Alana B. · director · last filing Jun 2025Robinson Byron · officer · last filing Jan 2025Lichter Jay · director · last filing Oct 2024Avalon Bioventures I, LP · 10% owner · last filing Oct 2024Avalon Bioventures Spv I, L.P. · 10% owner · last filing Oct 2024Avalon Ventures Xi, L.P. · 10% owner · last filing Oct 2024Reardon Tighe · officer · last filing Jun 2024Godfrey Wayne · officer · last filing Jan 2023Heller Stefan · director · last filing Jun 2022Thompson Peter A. · director · last filing Jun 2022Salek-Ardakani Shahram · officer · last filing Jan 2022Orbimed Advisors LLC · director · last filing Dec 2021Orbimed Capital Gp Viii LLC · director · last filing Dec 2021Orbimed Genesis Gp LLC · director · last filing Dec 2021Orbimed Capital Gp Vii LLC · director · last filing Dec 2021Bregua Corp · 10% owner · last filing Jun 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.